| 产品详情 |
| Edit |   |
|---|
| Product Name | O-1602 |
|---|
| Description | A potent and selective GPR55 agonist (EC50s = 13, >30,000, and >30,000 for GPR55, CB1, and CB2, respectively); reduces movement-induced firing of nociceptive C fibers in a rat model of inflammatory joint pain; decreases IL-6 and TNF-α levels and myeloperoxidase activities in the plasma, lungs, and pancreas in a mouse model of acute pancreatitis; reduces growth of Mz-ChA-1, HuCCT-1, CCLP-1, and SG231 cholangiocarcinoma cells at a concentration of 50 µM; reduces tumor growth in a Mz-ChA-1 mouse xenograft model; increases food intake and fat mass in rats, however, this effect was also observed in mice lacking GPR55, |
|---|
| Size | 25 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | Abn-CBDO|Abnormal Cannabidiorcin|Abnormal Cannabidiorcinol|Abnormal Cannabiorcodiol |
|---|
| Gene, Accession, CAS # | CAS: 317321-41-8 |
|---|
| Catalog # | 10006803-25 |
|---|
| Price | |
|---|
| Order / More Info | O-1602 from CAYMAN CHEMICAL COMPANY |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|